Navigation Links
Gerresheimer Holds its own in Difficult Environment
Date:7/15/2009

pplication of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.

    Group Key Figures
    (IFRS; End of Q2: May 31; Financial Year end November 30)

    in EUR million          Q2    Q2   Change % Q1-Q2 Q1-Q2 Change % FY 2008

                            2009  2008           2009  2008
    Net sales              264.4 276.3     -4.3 501.7 515.4     -2.7 1.060.1
    Group net sales
    excluding TPS(1)       251.6 257.2     -2.2 478.0 477.2     +0.2   985.9
    Adjusted EBITDA(2)      47.5  53.6    -11.4  85.8  96.6    -11.2   206.4
    in % of net sales       18.0  19.4           17.1  18.7             19.5
    Adjusted EBITDA(2)      47.5  N/A(3)         86.5  N/A(3)          N/A(3)
    excluding TPS
    in % of net sales       18.9  N/A(3)         18.1  N/A(3)          N/A(3)
    Profit from operations
    (EBIT)                  11.8  18.6    -36.6  21.0  33.5    -37.3    61.0
    Net income               0.9   5.6    -83.9  -0.1   8.2              4.5
    Adjusted net income(4)  14.3  17.6    -18.8  20.7  27.5    -24.7    61.4
    Earnings per share in
    EUR                     0.02  0.14    -85.7 -0.04  0.20             0.02
    Adjusted earnings
    per share(5) in EUR     0.44  0.53    -17.0  0.63  0.82    -23.2    1.83

---------------------------------

(1) Net sales of the recently divested Technical Plastics business (sold with effect from July 1, 2009) include the sales of the Technical Plastics tool business and amounted to EUR 74.2m in FY 2008

(2) Adjusted EBITDA: Earnings before income taxes, financial result, amortization of fair value adjustments, extraordinary depreciation, depreciation and amortization, restructuring expenses and one-off income and expenses

(3) The adjusted EBITDA of the Technical Plastic Systems business of the comparative prior year period is not avail
'/>"/>

SOURCE Gerresheimer AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board
2. 2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
3. Gerresheimer: Record Year in 2007 and Positive Outlook for 2008
4. Moodys Raises Rating for Gerresheimer
5. Gerresheimer Discontinues Marginal Operations
6. Gerresheimer Further Increases its Sales and Earnings Power
7. Gerresheimer Starts Process to Sell off its Business Segment of Technical Plastics
8. Gerresheimer Substantially Increases Quarterly Operating Profit
9. Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009
10. 2008 a Record Year for Gerresheimer
11. Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a pre-market ... (FDA) for the use of Medtronic,s SynchroMed ® ... catheter) for use with United Therapeutics, Remodulin ® ...
(Date:12/24/2014)... Texas , Dec. 24, 2014  Vermillion, Inc. ... on gynecologic disease, announced today that the Company ... including Oracle Investment Management, Jack W. Schuler ... Total proceeds were $10.5 million, before offering expenses.  ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market ... (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, ... Forecasts to 2019” provides a detailed overview of ... trends, and strategies impacting the preparative and process ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 Earlier this year ... Sherley, director of the Adult Stem Cell Technology Center, LLC ... under appreciated unique property of adult tissue stem cells. ... the Past, Important for the Future,” embodied the essence of ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... CHESTNUT HILL, MA -- Boston College researchers have discovered ... enhanced chemical vapor deposition, finding a disorderly tangle of ... the nanoscopic tubes, according to a report in the ... By using a thin layer of catalyst, Professor of ...
... MILFORD, Mass., Oct. 3, 2011 Waters Corporation ... of Minnesota,s Mass Spectrometry Laboratory into its ... Spectrometry Laboratory under the direction of Joseph Dalluge, Ph.D., for ... fibrosis and other diseases. He,s also honored for his research ...
... WASHINGTON, Oct. 3, 2011 Brainlab announced today the ... command and control center for information-guided surgery, is unveiling ... "Curve represents thousands of enhancements based ... feedback has always been a priority for Brainlab and ...
Cached Biology Technology:Boston College Researchers discover 2 early stages of carbon nanotube growth 2Waters Honors University of Minnesota's Joseph Dalluge, Ph.D. and Department of Chemistry Mass Spectrometry Laboratory with Center of Innovation Recognition 2Waters Honors University of Minnesota's Joseph Dalluge, Ph.D. and Department of Chemistry Mass Spectrometry Laboratory with Center of Innovation Recognition 3Waters Honors University of Minnesota's Joseph Dalluge, Ph.D. and Department of Chemistry Mass Spectrometry Laboratory with Center of Innovation Recognition 4Brainlab Launches Newest Innovation in Image Guided Surgery Technology 2Brainlab Launches Newest Innovation in Image Guided Surgery Technology 3
(Date:1/22/2015)... 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry ... new website design. "When we launched FindBiometrics 12 ... Peter O,Neill , founder and CEO of FindBiometrics. "Now it,s ... from the key players on a very broad scale.  We ...
(Date:1/22/2015)... Inc. (NASDAQ: NXTD and NXTDW) a biometric authentication company ... of the Wocket™ smart wallet at CES 2015 in Las ... one of the "11 Hot Products at CES" in a review published ... Far" by Newseveryday.com and "The top 10 gadgets from CES 2015" by ...
(Date:1/22/2015)... NEW YORK , Jan. 22, 2015   EyeLock, Inc. ... announced it has appointed Steve Gerber to the ... Gerber will be responsible for leading development of mobile platforms ... 25 years of success and innovation in the semiconductor industry ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... enable the deadly enterohemorrhagic Escherichia coli (EHEC) ... cells that line the digestive tract, according to a ... journal of the American Society for Microbiology. Gram-negative ... syringe-like weapons called type III secretion systems (T3SS) that ...
... (January 13, 2014) The Damon Runyon Cancer ... innovative early career researchers, named 15 new Damon ... review. The recipients of this prestigious, three-year ... translational cancer research in the laboratories of leading ...
... from Wisconsin will participate in a joint pilot program ... send them to a Chilean research station this February ... The U.S. students and teacher, from the ... peers--winners of Chile,s Antarctic School Fair--in the first Joint ...
Cached Biology News:Little but lethal -- small RNAs coordinate bacterial attack on epithelial cells 2Damon Runyon Cancer Research Foundation grants prestigious awards to 20 top young scientists 2Damon Runyon Cancer Research Foundation grants prestigious awards to 20 top young scientists 3Damon Runyon Cancer Research Foundation grants prestigious awards to 20 top young scientists 4Damon Runyon Cancer Research Foundation grants prestigious awards to 20 top young scientists 5Damon Runyon Cancer Research Foundation grants prestigious awards to 20 top young scientists 6Damon Runyon Cancer Research Foundation grants prestigious awards to 20 top young scientists 7Pilot program to let US high-school students experience Antarctic science at a Chilean station 2
... sequence corresponds to residues 115-133 of rat SAP97. The sequence ... L - P - S - E - R - I ... N - E - V - L - G - P ... conjugation and is not a part of the native rat SAP97 ...
... Have a novel target for which no ... Weve made custom antibodies for a variety of ... be happy to put our technology and expertise ... , Access to our patented RabMAb development technology ...
... SOS Protein Solubility Service, We ... , New SOS technology yields the best ... parameters applied on each clone submitted , ... ,The new protein Solubility Optimization Service ...
... II (Dual-Stage Quadrupole) Thermo Scientific (Part ... in analytical instrumentation, introduces the latest product ... II. Based on the proven reliability and ... GC/MS systems, the DSQ II incorporates the ...
Biology Products: